Genetically modulated substrate reduction therapy
The concept of enzyme replacement as a potential therapeutic approach to ameliorate lysosomal storage disorders (LSDs) is virtually as old as the concept of LSD itself. In fact, right after the first enzymatic deficiency underlying a LSD was described, both concepts were established and, for years,...
| Autor principal: | |
|---|---|
| Outros Autores: | , , |
| Formato: | conferenceObject |
| Idioma: | eng |
| Publicado em: |
2018
|
| Assuntos: | |
| Texto completo: | http://hdl.handle.net/10400.18/5516 |
| País: | Portugal |
| Oai: | oai:repositorio.insa.pt:10400.18/5516 |